The man who discovered his family secrets – via his DNA

Greg Lucier, who has devoted his career to genetics, was shocked by what his own profile revealed, he tells Jeremy Laurance

Technology set to transform medicine has already changed the life of the man leading its development. Greg Lucier, chief executive of Life Technologies, the Californian company that makes machines for reading the human genome, decided to "see what it would be like" to have his genetic profile analysed – and uncovered hidden facts about his family's health.

In his late forties, Mr Lucier discovered he was carrying a mutation of an unusual form of Parkinson's disease, a degenerative disorder with no cure. Subsequent testing of his mother, Anne, 79, who had been suffering from an ailment labelled "multiple systems atrophy", established that she, too, had the mutation – and also Parkinson's.

That was not all. When his genome was sequenced in June of last year Mr Lucier discovered he had a mutation linked with breast cancer. While that poses little risk to him, if his wife also carries it and his 15-year-old daughter has inherited it from both her parents, she will be at high risk of breast cancer. Unlike Parkinson's, breast cancer can be dealt with through screening, early diagnosis and prompt treatment. Sequencing his daughter's genome could save her life by ensuring she undergoes early and regular mammographic screening.

Mr Lucier said: "When I found out I had the mutation for Parkinson's I knew it typically develops later in life and it was only a probability I would get it. I wasn't going to worry."

The family wanted to know what was wrong with his mother and she submitted to the test willingly, because she was interested in the technology and what it could do.

"My mother is a very curious woman. She is late in life and recognises there is no cure for Parkinson's but her whole psychology is to help the next generation. This is about humanity for her." She is shortly to undergo brain scans and have stem cells extracted to assist the research effort.

His father declined a test, though he has consented to have his cells preserved for analysis after his death. "He is a very fatalistic fellow. He said to me: 'Presume the worst case scenario – would [knowing about it] make any difference?'"

Learning whether his father carried the same mutation as his mother and himself "would have added a lot" in helping to calculate his own risk. But assuming the worst was just as good a basis for any decisions, he said. Genetic profiling offers patients personal risk analyses, predicting their chance of developing diseases, and enables doctors to tailor treatments to their genetic inheritance. Critics argue that there is questionable benefit, and that there may be harm, in learning you are at high risk of a terminal disease. The prospect of living under such a threat, possibly for decades, leads some to reject gene testing.

But Mr Lucier points to the second discovery he made – of the mutation for breast cancer – as evidence of the immediate benefits the technology could bring. "If my daughter carries breast cancer mutations from both her parents then she needs to get early mammography. That is an example where there is action that can be taken now that is clearly of benefit."

The cost of DNA sequencing is plunging and its speed accelerating. Mr Lucier says his billion-dollar company already has the kit to produce an affordable $1,000 (£600) genome which will be on the market "within 12 months". The first complete human genome produced a decade ago cost $3bn.

The technology will allow doctors to adapt treatments to fit the genetic profile of the patient and of the disease, introducing "personalised medicine" with higher success rates. A drawback is that patients who might be suitable for treatment with the new targeted drugs must first be tested to see if they have the right genetic profile – and the tests add to the expense.

Mr Lucier says cancer treatment is the key area in which genetic profiling could bring immediate benefit. Pilot schemes to introduce genetic testing of tumours is to be rolled out next month in seven British hospitals by Cancer Research UK. The next step would be genetic profiling of patients.

"If you have a cancer today you need to get your genome sequenced. It will allow doctors to understand what is driving the cancer and what may be done in the way of treatment. Drugs for cancer work in only one in five patients and they cost tens of thousands of dollars. Our understanding is increasing at an incredible pace. This is how medicine is going to change."

Life and Style
food + drink
Life and Style
love + sex A new study has revealed the average size - but does that leave men outside the 'normal' range being thought of as 'abnormal'?
Life and Style
Tikka Masala has been overtaken by Jalfrezi as the nation's most popular curry
food + drink
UK Border Control
Life and Style
ebookNow available in paperback
ebookPart of The Independent’s new eBook series The Great Composers
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Sales Executive - OTE £45-55k

    £20000 - £55000 per annum: Recruitment Genius: The company is an established, ...

    Recruitment Genius: E-Commerce Manager - Fashion Accessories

    £25000 - £30000 per annum: Recruitment Genius: This is a great opportunity for...

    Recruitment Genius: Accounts Senior / Assistant Manager

    Negotiable: Recruitment Genius: Exciting new position available at an independ...

    Recruitment Genius: Bookkeeper / Credit Controller

    £20000 - £24000 per annum: Recruitment Genius: The successful candidate will h...

    Day In a Page

    Syrian conflict is the world's first 'climate change war', say scientists, but it won't be the last one

    Climate change key in Syrian conflict

    And it will trigger more war in future
    How I outwitted the Gestapo

    How I outwitted the Gestapo

    My life as a Jew in wartime Berlin
    The nation's favourite animal revealed

    The nation's favourite animal revealed

    Women like cuddly creatures whilst men like creepy-crawlies
    Is this the way to get young people to vote?

    Getting young people to vote

    From #VOTESELFISH to Bite the Ballot
    Poldark star Heida Reed: 'I don't think a single bodice gets ripped'

    Poldark star Heida Reed

    'I don't think a single bodice gets ripped'
    The difference between America and Israel? There isn’t one

    The difference between America and Israel? There isn’t one

    Netanyahu knows he can get away with anything in America, says Robert Fisk
    Families clubbing together to build their own affordable accommodation

    Do It Yourself approach to securing a new house

    Community land trusts marking a new trend for taking the initiative away from developers
    Head of WWF UK: We didn’t send Cameron to the Arctic to see green ideas freeze

    David Nussbaum: We didn’t send Cameron to the Arctic to see green ideas freeze

    The head of WWF UK remains sanguine despite the Government’s failure to live up to its pledges on the environment
    Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

    Author Kazuo Ishiguro on being inspired by shoot-outs and samurai

    Set in a mythologised 5th-century Britain, ‘The Buried Giant’ is a strange beast
    With money, corruption and drugs, this monk fears Buddhism in Thailand is a ‘poisoned fruit’

    Money, corruption and drugs

    The monk who fears Buddhism in Thailand is a ‘poisoned fruit’
    America's first slavery museum established at Django Unchained plantation - 150 years after slavery outlawed

    150 years after it was outlawed...

    ... America's first slavery museum is established in Louisiana
    Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

    Kelly Clarkson: How I snubbed Simon Cowell and become a Grammy-winning superstar

    The first 'American Idol' winner on how she manages to remain her own woman – Jane Austen fascination and all
    Tony Oursler on exploring our uneasy relationship with technology with his new show

    You won't believe your eyes

    Tony Oursler's new show explores our uneasy relationship with technology. He's one of a growing number of artists with that preoccupation
    Ian Herbert: Peter Moores must go. He should never have been brought back to fail again

    Moores must go. He should never have been brought back to fail again

    The England coach leaves players to find solutions - which makes you wonder where he adds value, says Ian Herbert
    War with Isis: Fears that the looming battle for Mosul will unleash 'a million refugees'

    The battle for Mosul will unleash 'a million refugees'

    Aid agencies prepare for vast exodus following planned Iraqi offensive against the Isis-held city, reports Patrick Cockburn